Top News

Achaogen Up In IPO

South San Francisco-based Achaogen raised $72M in its IPO, and was up in trading during the day, after debuting at $12 per share this morning on the NASDAQ Global Market as AKAO. The company, which develops antibiotics aimed at drug-resistant infections, priced at $12.00 per share last night, at the high end of its initial $10.00 to $12.00 per share range. Achaogen was venture backed by Domain Associate,s Venrock, The WellCome Trust, Arch Venture Partners, Versant Ventures, Omega Fund, 5AM Ventures, as well as others.


 

Marketplace


blog comments powered by Disqus
 

Latest Headlines

Browse Issues